Chengdu Maipu Industry Group

Hua Xuan, the founder and chairman, is the central decision-maker. He built his career in telecom equipment with Maipu Communication before transitioning into a diversified investment posture. The group operates as a corporate investor without external limited partners, meaning capital allocation and portfolio decisions flow through Hua and his internal team rather than through an institutional investment committee.

Maipu Medical, also known as Medprin, is a medical device and regenerative medicine company incubated by the Maipu Group. Yuan Yuyu, a business partner of Hua Xuan, serves as Medprin's founder. This relationship reflects the group's approach of actively building operating companies in targeted sectors rather than limiting itself to minority venture positions.

Yes. The group holds Maipu Mansion, a commercial property at No. 16 Jiuxing Avenue, and the Maipu Science and Technology Park at No. 22 Xixin Avenue, both in Chengdu's High-tech District. These assets serve both investment purposes and as operational anchors for the group's technology and incubation activities.

Chengdu has developed into a significant technology and venture hub in western China, with a strong pool of engineering talent and lower operating costs than coastal cities. Maipu's physical presence — including its science park — positions the group to access local deal flow and provide portfolio companies with infrastructure support, a differentiator from Beijing- or Shanghai-concentrated investors.